`
Saturday, 24 June 2017

Vaccines News

  • J&J's HIV vaccine to begin human trials

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2015

    Singapore: Bringing new hope to millions of people worldwide, the experimental HIV vaccine developed by Johnson & Johnson has shown promise in early clinical trials. As per reports the ...Read more

  • Agilent, A*Star, French univ sign biologics MoU

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 27 May, 2013

    Singapore: Agilent Technologies, Glyco-MEV laboratory at the University of Rouen, France, and Bioprocessing Technology Institute (BTI) at the Agency for Science, Technology and Research (A*...Read more

  • Stanford Univ reverse vaccine to treat diabetes

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 28 Jun, 2013

    Singapore: Scientists at Stanford University, US, and Leiden University Medical Center in the Netherlands, have tested a 'reverse vaccine' that dampens the immune systems of people with typ...Read more

  • EU approves Merck's Keytruda for melanoma

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2015

    Merck has announced that the European Commission has approved KEYTRUDA (pembrolizumab), its anti-PD-1 therapy, for the treatment of advanced (unresectable or metastatic) melanoma in adults...Read more

  • Astellas, ClearPath to enter strategic partnership

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 06 Jan, 2014

    Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious dis...Read more

  • Sanofi gears up to introduce dengue vaccine

    Vaccines |  Influencers | By Amrita Tejasvi | 0 Comment | 15 Aug, 2014

    Healthcare stakeholders are keeping high hopes with the successful results of Sanofi Pasteur's Phase III trial of dengue vaccine completed this year and a vaccine may be available soon. The...Read more

  • India's vaccine future looks bright despite hurdles

    Vaccines |  Analysis | By Manasi Vaidya | 0 Comment | 24 Apr, 2013

    The Indian vaccine industry has been in the past few years following close on the footsteps of the Indian pharma sector. The vaccine industry has been making concerted efforts to develop va...Read more

  • HIV vaccine dream can now be a reality

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 11 Mar, 2013

    Singapore: Scientists at Vaccine and Gene Therapy Institute of Florida (VGTI), US, a nonprofit immunological research institute, showed that previously unidentified dysfunction in follicula...Read more

  • Imaxio starts human trials with re-engineered TB antigen

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2013

    Singapore: Vaccine firm Imaxio's proprietary pro-immunogenic technology, IMX313, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The tri...Read more

  • A push to accelerate next-gen immunogen design

    Vaccines |  Analysis | By Amrita Tejasvi | 0 Comment | 19 Jul, 2012

    According to the International AIDS Vaccine Initiative (IAVI), in September 2009, scientists reported isolation of a pair of potent and broadly neutralizing antibodies against HIV. That dis...Read more

  • World Immunization Week: WHO urges renewed efforts

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 25 Apr, 2015

    Singapore: Dr Poonam Khetrapal Singh, regional director, WHO South-East Asia, in her message has called for ensuring equity with the lifesaving drugs. "Every year vaccination averts 2 to 3 ...Read more

  • Thai HIV vaccine shows promise in clinical trials

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 12 Nov, 2014

    Singapore: The Thai HIV vaccine that showed promise in initial clinical trials held in Thailand in 2009, has also exhibited significant protection in a clinical trial held in South Africa. ...Read more

  • Painless vaccination unveiled!

    Vaccines |  Influencers | By Aishwarya Venkatesh | 0 Comment | 01 May, 2015

    Singapore: Though vaccination is considered the most important procedure for healthcare and disease management, it is not widely accepted by all sections of the society. Vaccination can be...Read more

  • Bangladesh adds 2 new vaccines to Immunization Program

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 25 Mar, 2015

    Singapore: Two new vaccines have been added to Bangladesh's national immunization program- Pneumococcal vaccine (PCV) and an Inactivated Polio Vaccine (IPV). Health officials stated that th...Read more

  • China strengthens vaccine controls

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 15 May, 2015

    Singapore: In a bid to increase the penetration of immunization programs in rural areas, the Chinese government recently issued a circular to improve management of vaccination programs in t...Read more

  • Soon, a single flu shot may offer universal immunity!

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 19 May, 2015

    Singapore: A single vaccine that immunizes against all types of influenza may soon be a reality, after a team of scientists from Australia and China have discovered how the body's immunity ...Read more

  • Takeda transfers HPV vaccine license to Japanese firm

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2015

    Singapore: Takeda Pharmaceutical has transferred its license agreement with the Japan Health Sciences Foundation (HS Foundation) for worldwide patent rights of a human papillomavirus (HPV) ...Read more

  • Vaccine worth $1.3 million spoils in Pakistan

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 13 Mar, 2015

    Singapore: According to recent reports from the National Health Services of Pakistan, pentavalent vaccine worth nearly $1.3 million has spoiled in a store room in Pakistan. The vaccine, en...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls